drugset / Trial / NCT06994052

Study on Booster Immunization With Varicella Vaccine at Different Intervals

NCT06994052

Phase 4 Completed 412 enrolled Sinovac (Dalian) Vaccine Technology Co., Ltd.
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The goal of this clinical trial is to evaluate the immunogenicity and safety of booster immunization of varicella live attenuated vaccine (varicella vaccine hereafter) at different intervals.

Timeline

Start
2024-09-21
Primary completion
2024-11-30
Completion
2024-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Varicella vaccine Vaccine Subcutaneous

Indications